For the first time, scientists have shown that in certain people living with HIV, a type of antibody called immunoglobulin G3 (IgG3) stops the immune system's B cells from doing their normal job of fighting pathogens. This ...
112
0
Bacteria—especially Gram-negative strains—are becoming increasingly resistant to current antibiotic drugs, and the development of new classes of antibiotics has slowed. Faced with these challenges, investigators are studying ...
3
0
A study led by researchers at Center for Infection and Immunity (CII) at Columbia University's Mailman School of Public Health and the Department of Medicine at the Columbia University Irving Medical Center reports on the ...
0
0
Food can become contaminated with pathogenic bacteria even when hygiene standards in a kitchen, whether domestic or commercial, and in the food industry. There are so many possible microbes that can come into contact with ...
0
0
Antibiotic use is driving an epidemic of antibiotic resistance, as more susceptible bacteria are killed but more resilient strains live on and multiply with abandon. But if antibiotics aren't the end-all solution for infectious ...
4596
1
A team at Scripps Research has come up with a faster way to analyze the outcome of experimental vaccines against HIV and other pathogens. Their new system lets scientists quickly assess the full spectrum of antibodies produced ...
42
0
Researchers at the Stanford University School of Medicine have identified a molecule that serves as natural protection against one of the most common intestinal pathogens.
527
0
Researchers at the RIKEN Center for Integrative Medical Science in Japan have discovered how antibodies secreted in the gut promote the growth of beneficial bacteria. Their study, which will be published July 24 in the Journal ...
176
0
A nationwide investigation of the prevalence and distribution of ticks and exposure to tick-borne diseases highlights the value of public participation in science. The study, published on July 11th in the open-access journal ...
1
0
Researchers have identified a protein that powers the virulence of the bacteria that causes gonorrhea, opening the possibility of a new target for antibiotics and, even better, a vaccine.
209
0
